CapWealth Advisors LLC Sells 7,924 Shares of CVS Health Corporation $CVS

CapWealth Advisors LLC reduced its stake in shares of CVS Health Corporation (NYSE:CVS) by 2.4% in the third quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 318,909 shares of the pharmacy operator’s stock after selling 7,924 shares during the quarter. CVS Health makes up approximately 2.2% of CapWealth Advisors LLC’s investment portfolio, making the stock its 19th largest position. CapWealth Advisors LLC’s holdings in CVS Health were worth $24,043,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently added to or reduced their stakes in the stock. Cantor Fitzgerald Investment Advisors L.P. increased its position in shares of CVS Health by 1.6% during the second quarter. Cantor Fitzgerald Investment Advisors L.P. now owns 409,735 shares of the pharmacy operator’s stock worth $28,264,000 after acquiring an additional 6,615 shares during the period. Aaron Wealth Advisors LLC increased its holdings in CVS Health by 177.4% during the 3rd quarter. Aaron Wealth Advisors LLC now owns 34,259 shares of the pharmacy operator’s stock worth $2,583,000 after purchasing an additional 21,911 shares during the period. Red Mountain Financial LLC bought a new stake in CVS Health during the 2nd quarter valued at $293,000. Osaic Holdings Inc. lifted its holdings in shares of CVS Health by 18.4% in the 2nd quarter. Osaic Holdings Inc. now owns 229,903 shares of the pharmacy operator’s stock worth $15,828,000 after buying an additional 35,809 shares during the period. Finally, AE Wealth Management LLC grew its position in shares of CVS Health by 607.5% during the 2nd quarter. AE Wealth Management LLC now owns 242,221 shares of the pharmacy operator’s stock worth $16,708,000 after buying an additional 207,984 shares in the last quarter. Hedge funds and other institutional investors own 80.66% of the company’s stock.

CVS Health Stock Down 0.6%

Shares of CVS stock opened at $79.35 on Friday. The stock’s fifty day moving average price is $78.71 and its 200 day moving average price is $73.28. CVS Health Corporation has a 1-year low of $43.72 and a 1-year high of $85.15. The company has a market cap of $100.73 billion, a price-to-earnings ratio of 208.82, a price-to-earnings-growth ratio of 0.78 and a beta of 0.48. The company has a debt-to-equity ratio of 0.83, a current ratio of 0.83 and a quick ratio of 0.63.

CVS Health (NYSE:CVS) last issued its quarterly earnings results on Wednesday, October 29th. The pharmacy operator reported $1.60 earnings per share for the quarter, topping analysts’ consensus estimates of $1.36 by $0.24. The business had revenue of $102.87 billion for the quarter, compared to analyst estimates of $98.85 billion. CVS Health had a return on equity of 11.45% and a net margin of 0.12%.The company’s revenue was up 7.8% on a year-over-year basis. During the same quarter in the previous year, the firm earned $1.09 earnings per share. CVS Health has set its FY 2025 guidance at 6.550-6.650 EPS. On average, research analysts expect that CVS Health Corporation will post 5.89 earnings per share for the current fiscal year.

Analyst Upgrades and Downgrades

CVS has been the subject of several recent research reports. Wolfe Research lifted their price objective on CVS Health from $85.00 to $100.00 and gave the company an “outperform” rating in a report on Monday, December 8th. Jefferies Financial Group upped their price target on shares of CVS Health from $92.00 to $98.00 in a research report on Thursday, October 30th. Wall Street Zen lowered shares of CVS Health from a “buy” rating to a “hold” rating in a report on Saturday, November 1st. Sanford C. Bernstein upped their target price on CVS Health from $86.00 to $87.00 and gave the stock a “market perform” rating in a report on Friday, December 12th. Finally, Evercore ISI lifted their price target on CVS Health from $85.00 to $95.00 and gave the company an “outperform” rating in a report on Thursday, October 30th. Two equities research analysts have rated the stock with a Strong Buy rating, twenty have given a Buy rating and four have given a Hold rating to the company’s stock. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and an average target price of $94.67.

About CVS Health

CVS Health Corporation is a diversified healthcare company that operates a large network of retail pharmacies, pharmacy benefit management services and health care solutions. Headquartered in Woonsocket, Rhode Island, the company traces its roots to the early 1960s and has grown into an integrated provider of prescription drugs, over‑the‑counter products, clinical services and health insurance offerings. Its operating model combines retail pharmacy locations and in‑store clinics with broader pharmacy and health plan capabilities.

Key business activities include CVS Pharmacy retail operations, MinuteClinic walk‑in medical clinics and HealthHUB locations that offer expanded clinical services.